Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nyxoah SA

6.14
+0.15002.50%
Volume:68.42K
Turnover:409.24K
Market Cap:229.80M
PE:-3.28
High:6.20
Open:5.93
Low:5.81
Close:5.99
Loading ...

Publication relating to transparency notifications

GlobeNewswire
·
21 Dec 2024

Tongue Implant Could Treat Sleep Apnea Without a CPAP

Design & Development Today
·
13 Dec 2024

Nyxoah Commercially Launches Genio Therapy in England; Shares Up Pre-Bell

MT Newswires Live
·
13 Dec 2024

Nyxoah announces commercial launch of Genio system in England

TIPRANKS
·
13 Dec 2024

Nyxoah Launches Genio System in England for OSA

TIPRANKS
·
13 Dec 2024

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

GlobeNewswire
·
13 Dec 2024

Nyxoah to Present at Healthcare Conference Amidst Growth

TIPRANKS
·
21 Nov 2024

Nyxoah’s Voting Rights Shift with ResMed Stake

TIPRANKS
·
19 Nov 2024

Nyxoah SA (NYXH) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

GuruFocus.com
·
07 Nov 2024

Nyxoah SA Reports Growth Amid Clinical Advances

TIPRANKS
·
07 Nov 2024

Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
07 Nov 2024

Nyxoah Eyes Strong US Launch Amid Financial Growth

TIPRANKS
·
07 Nov 2024

Nyxoah Q3 EPS $(0.55) Misses $(0.46) Estimate, Sales $1.39M Miss $1.48M Estimate

Benzinga
·
07 Nov 2024

Nyxoah Reports Third Quarter Financial and Operating Results

GlobeNewswire
·
07 Nov 2024

Nyxoah Strengthens Leadership for U.S. and Global Expansion

TIPRANKS
·
05 Nov 2024

Nyxoah SA expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
04 Nov 2024

Privia Health (PRVA) Earnings Expected to Grow: Should You Buy?

Zacks
·
31 Oct 2024

Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks
·
30 Oct 2024